Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

12/02/2025 06:33

Feb 12 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              225.90              201.16           320.00    
                   (+12.3 pct)         (+14.1 pct)      (+18.2 pct) 
  Operating           32.27               35.26            43.20    
                   (-8.5 pct)          (+23.3 pct)      (+7.9 pct)  
  Recurring           33.38               37.25            44.20    
                   (-10.4 pct)         (+26.1 pct)      (+4.2 pct)  
  Net                 24.81               26.16            32.20    
                   (-5.2 pct)          (+20.9 pct)      (+4.1 pct)  
  EPS              108.73 yen          114.66 yen       141.14 yen  
  EPS Diluted      108.42 yen          114.33 yen                   
  Ann Div                               27.00 yen        36.00 yen  
  -Q2 div           16.00 yen           12.00 yen                   
  -Q4 div                               15.00 yen        20.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T